People

Michael Birrer, MD, PhD, became director of the Winthrop P. Rockefeller CancerInstitute in Little Rock, AR, replacing interim director LauraHutchins, MD. Birrer was formerly the director of the O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham. He was also a professor of medicine at Harvard Medical School and the director of Gynecologic Medical Oncology at Massachusetts General Hospital and the Gynecologic Oncology Research Program at the Dana-Farber/Harvard Cancer Center, all in Boston.

On January 1, Levi Garraway, MD, PhD, became chief medical officer and head of Global Product Development at Roche, replacing Sandra Horning, MD, who retired. Most recently, he was senior vice president of Eli Lilly's Oncology Research and Development and head of Lilly Research Laboratories Novel Target Research. Garraway has also served as director of the Joint Center for Cancer Precision Medicine, which includes Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital, as well as the Broad Institute of MIT and Harvard in Cambridge, MA. In 2010, he cofounded Foundation Medicine.

In December, Robert Winn, MD, began his role as director of the Virginia Commonwealth University Massey Cancer Center in Richmond, replacing Gordon Ginder, MD. Previously, Winn served as director of the University of Illinois Cancer Center in Chicago and as associate vice chancellor of community-based practice at the University of Illinois Hospital and Health Sciences System. His research focuses on lung cancer, including mechanistic drivers of the disease and the role of cellular senescence.

For more news on cancer research, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.